JP2022518944A5 - - Google Patents

Info

Publication number
JP2022518944A5
JP2022518944A5 JP2021544351A JP2021544351A JP2022518944A5 JP 2022518944 A5 JP2022518944 A5 JP 2022518944A5 JP 2021544351 A JP2021544351 A JP 2021544351A JP 2021544351 A JP2021544351 A JP 2021544351A JP 2022518944 A5 JP2022518944 A5 JP 2022518944A5
Authority
JP
Japan
Prior art keywords
diazaspiro
trifluoroethoxy
decane
pyrimidine
biphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021544351A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518944A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000074 external-priority patent/WO2020157577A1/en
Publication of JP2022518944A publication Critical patent/JP2022518944A/ja
Publication of JP2022518944A5 publication Critical patent/JP2022518944A5/ja
Pending legal-status Critical Current

Links

JP2021544351A 2019-01-30 2020-01-30 肺動脈性肺高血圧症を治療するための投与レジメンおよび方法 Pending JP2022518944A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962798827P 2019-01-30 2019-01-30
US62/798,827 2019-01-30
PCT/IB2020/000074 WO2020157577A1 (en) 2019-01-30 2020-01-30 A dosage regime and method for treating pulmonary arterial hypertension with rodatristat ethyl

Publications (2)

Publication Number Publication Date
JP2022518944A JP2022518944A (ja) 2022-03-17
JP2022518944A5 true JP2022518944A5 (cg-RX-API-DMAC7.html) 2022-12-19

Family

ID=70285725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021544351A Pending JP2022518944A (ja) 2019-01-30 2020-01-30 肺動脈性肺高血圧症を治療するための投与レジメンおよび方法

Country Status (9)

Country Link
US (2) US11607413B2 (cg-RX-API-DMAC7.html)
EP (1) EP3917531A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022518944A (cg-RX-API-DMAC7.html)
KR (1) KR20210133953A (cg-RX-API-DMAC7.html)
CN (1) CN113557022A (cg-RX-API-DMAC7.html)
AU (1) AU2020213746A1 (cg-RX-API-DMAC7.html)
CA (1) CA3128327A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021009055A (cg-RX-API-DMAC7.html)
WO (1) WO2020157577A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210102887A (ko) * 2018-11-14 2021-08-20 알타반트 사이언시스 게엠베하 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
AU2019382168A1 (en) 2018-11-16 2021-06-03 Altavant Sciences Gmbh A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
WO2020128614A1 (en) * 2018-12-17 2020-06-25 Altavant Sciences Gmbh Method for treating interstital lung disease
CN113557022A (zh) 2019-01-30 2021-10-26 阿尔塔万特科学公司 用罗达司他乙酯治疗肺动脉高压的给药方案和方法
CN113784717A (zh) * 2019-03-15 2021-12-10 阿尔塔万特科学公司 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药
WO2023062595A1 (en) 2021-10-14 2023-04-20 Altavant Sciences Gmbh Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101815534A (zh) 2007-07-11 2010-08-25 莱西肯医药有限公司 用于治疗肺动脉高压以及相关疾病和病症的方法和组合物
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
KR20210102887A (ko) 2018-11-14 2021-08-20 알타반트 사이언시스 게엠베하 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
AU2019382168A1 (en) 2018-11-16 2021-06-03 Altavant Sciences Gmbh A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
US20200188398A1 (en) 2018-12-17 2020-06-18 Altavant Sciences Gmbh Method for treating sarcoidosis-associated pulmonary hypertension
WO2020128614A1 (en) 2018-12-17 2020-06-25 Altavant Sciences Gmbh Method for treating interstital lung disease
CN113557022A (zh) 2019-01-30 2021-10-26 阿尔塔万特科学公司 用罗达司他乙酯治疗肺动脉高压的给药方案和方法
CN113784717A (zh) * 2019-03-15 2021-12-10 阿尔塔万特科学公司 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药

Similar Documents

Publication Publication Date Title
US6335021B1 (en) Composition for controlling mood disorders in healthy individuals
CN106999467A (zh) 治疗认知减退的方法
US11045447B2 (en) Methods for inducing synaptogenesis with synaptic growth factor activating compounds
CN107519159A (zh) 复方组合物
US20160030383A1 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
KR101951220B1 (ko) 조합 als 치료법
RU2010109359A (ru) Азитромицин для лечения кожных заболеваний
JP2024019691A (ja) 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
JP2010065060A (ja) 心不全処置のための複合治療
JP2016505050A5 (cg-RX-API-DMAC7.html)
WO2020128608A1 (en) Compound for use in a method for treating sarcoidosis-associated pulmonary hypertension
JP2025511402A5 (cg-RX-API-DMAC7.html)
JP2025511401A5 (cg-RX-API-DMAC7.html)
CN109172550B (zh) 一种复合麻醉药物
AU2013362755B2 (en) Uses and methods for the treatment of liver diseases or conditions
JP2022019937A (ja) ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物
CN113827590A (zh) 右美托咪定在助眠药物制备中的应用
TW201244732A (en) Ezatiostat for treating multiple myeloma
EP4029503B1 (en) Drug combinations of entecavir and a tlr7 agonist for use in the treatment of hbv
AU2013301125B2 (en) A3 adenosine receptor ligands for use in treatment of a sexual dysfunction
US20190381034A1 (en) Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases
RU2404976C1 (ru) Средство, снижающее влечение к алкоголизму, фармацевтическая композиция, способ ее получения, лекарственное средство и способ лечения
TW536400B (en) Pharmaceutical composition for the treatment of immunodeficiency disease which cause by HIV infection
JP2004026810A (ja) 鼻炎用組成物